Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.
WR 151327
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Combined injuries, which are expected after a radiation dispersal device release or nuclear weapon detonation, are the… Expand
Is this relevant?
2001
2001
The effect of combining a radiation-protective phosphorothioate with another agent was investigated in an attempt to increase… Expand
Is this relevant?
2000
2000
PURPOSE
To determine the efficacy of WR-151327 (WR) [S-3-(3-methylaminopropylamino) propylphosphorothioic acid; (CH3-HN-(CH2)3-NH… Expand
Is this relevant?
1994
1994
Clinical trials are in progress to evaluate radio- and chemoprotection by the aminothiol 2-[(3-aminopropyl)amino]ethanethiol… Expand
Is this relevant?
1994
1994
Reducing agents such as glutathione (GSH), glutathione ester (GSE), and N-acetylcysteine (NAC) have been shown to suppress the… Expand
Is this relevant?
1994
1994
PURPOSE
To evaluate the protective effect of WR-151327 on late radiation-induced damage to normal tissues in mice.
METHODS AND… Expand
Is this relevant?
1992
1992
Pathological evaluation of WR-151327 administered orally in irradiated and non-irradiated male mice.
Studies were made on the radioprotective and toxic effects of orally administered WR-151327 in male CD2F1 mice. The lowest dose… Expand
Is this relevant?
1991
1991
The mutagenic and carcinogenic properties of fission-spectrum neutrons (KERMA-weighted mean energy of 0.85 MeV) from Argonne… Expand
Is this relevant?
1990
1990
The systemic effects of the radiation protective agent, S-3-(3-methylaminopropylamino) propylphosphorothioic acid (WR-151327… Expand
Is this relevant?
1987
1987
Two phosphorothioate compounds, WR-2721 and WR-151327, were examined for their radioprotective efficacies against the effects of… Expand
Is this relevant?